THYROID GLAND SQUAMOUS CELL CARCINOMA
Clinical trials for THYROID GLAND SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against deadly thyroid cancer before surgery
Disease control OngoingThis study tests whether giving three drugs (pembrolizumab, dabrafenib, and trametinib) before surgery can help control a rare and aggressive thyroid cancer called anaplastic thyroid cancer that has a specific gene change (BRAF V600E). The goal is to make surgery more successful …
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:43 UTC
-
Personalized cell therapy takes on resistant cancers
Disease control OngoingThis study tests a treatment made from a patient's own immune cells (called LN-145) for cancers like ovarian, triple-negative breast, anaplastic thyroid, and bone sarcomas that have not responded to standard therapy or have returned. The cells are taken from the tumor, grown in a…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New combo therapy shows promise for rare, aggressive thyroid cancer
Disease control OngoingThis study tests whether combining lenvatinib (a drug that blocks cancer cell growth) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can help people with advanced anaplastic thyroid cancer that cannot be removed by surgery or has spread. The tria…
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
New drug shrinks thyroid tumors before surgery in early trial
Disease control OngoingThis study tests whether giving the drug selpercatinib before surgery can shrink thyroid cancers that have a specific genetic change (RET alteration). About 30 people with advanced or recurrent thyroid cancer will receive the drug and then have surgery. The goal is to see if the …
Matched conditions: THYROID GLAND SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:28 UTC